Abstract
Autism spectrum disorder (ASD) is characterized by impaired social interaction and communication, restricted interests and repetitive behaviors. Fragile X E is associated with X-linked non-specific mild intellectual disability (ID) and with behavioral problems. Most of the known genetic causes of ASD are also causes of ID, implying that these two identities share common genetic bases. We present a child with an ASD with a normal range of intelligence quotient, that later evolved to compulsive behavior. FRAXE locus analysis by polymerase chain reaction revealed a complete mutation of the FMR 2 gene. This report stresses the importance of clinicians being aware of the association between a full mutation of FMR2 and ASD associated with compulsive behavior despite normal intellectual level.
References
Allingham-Hawkins, D., & Ray, P. (1995). FRAXE expansion is not a common etiological factor among developmentally delayed males. American Journal of Human Genetics, 56, 72–76.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed, text rev.).
Barnicoat, A., Wang, Q., Turk, J., Green, E., Mathew, C., Flynn, G., et al. (1997). Clinical, cytogenetic, and molecular analysis of three families with FRAXE. Journal of Medical Genetics, 34, 13–17.
Bensaid, M., Melko, M., Bechara, E., Davidovic, L., Berretta, A., Catania, M., et al. (2009). FRAXE-associated mental retardation protein (FMR2) is an RNA-binding protein with high affinity for G-quartet RNA forming structure. Nucleic Acids Research, 37(4), 1269–1279.
Brown, W. (1996). The FRAXE syndrome: Is it time for routine screening? American Journal of Human Genetics, 58, 903–905.
Chan, S. Y., & Wong, V. (1998). DNA diagnosis of FRAXA and FRAXE in Chinese children with neurodevelopmental disorders and fragile X syndrome. Clinical Genetics, 53(3), 179–183.
Cook, D., Nuro, E., & Murai, K. K. (2013). Increasing our understanding of human cognition through the study of fragile X syndrome. Developmental Neurobiology, 31, 1–72.
Flynn, G., Hirst, M., Knight, S., Macpherson, J., Barber, J., Flannery, A., et al. (1993). Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation. Journal of Medical Genetics, 30, 97–100.
Gécz, J. (2000). The FMR2 gene, FRAXE and non-specific X-linked mental retardation: Clinical and molecular aspects. Annals of Human Genetics, 64, 95–106.
Gécz, J., Gedeon, A. K., Sutherland, G. R., & Mulley, J. C. (1996). Identification of the gene FMR2, associated with FRAXE mental retardation. Nature Genetics, 13(1), 105–108.
Gécz, J., Oostra, B., Hockey, A., Carbonell, P., Turner, G., Haan, E., et al. (1997). FMR2 expression in families with FRAXE mental retardation. Human Molecular Genetics, 6(3), 435–441.
Gedeon, A., Keinanen, M., Ades, C., Kaariainen, H., Gecz, J., Baker, E., et al. (1995). Overlapping submicroscopic deletions in Xq28 in two unrelated boys with developmental disorders: Identification of a gene near FRAXE. American Journal of Human Genetics, 56, 907–914.
Gu, Y., Shen, Y., Gibbs, R. A., & Nelson, D. L. (1996). Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nature Genetics, 13(1), 109–113.
Hillman, M. A., & Gécz, J. (2001). Fragile XE-associated familial mental retardation protein 2 (FMR2) acts as a potent transcription activator. Journal of Human Genetics, 46(5), 251–259.
Hirst, M., Barnicoat, A., Flynn, G., Wang, Q., Daker, M., Buckle, V. J., et al. (1993). The identification of a third fragile site, FRAXF in Xq27-28 distal to both FRAXA and FRAXE. Human Molecular Genetics, 2, 197–200.
Holden, JJ., Wing, M., Chalifoux, M., Julien-Inalsingh, C., Schutz, C., Robinson, P., et al. (1996). Lack of expansion of triplet repeats in the FMR1, FRAXE, and FRAXF loci in male multiplex families with autism and pervasive developmental disorders. Am J Med Genet, Aug; 64(2):399-403.
Holinski-Feder, E., Chahrokh-Zadeh, S., Jedele, K., Meindl, A., Steinbach, P., & Wohrle, D. (1996). FRAXE testing. American Journal of Human Genetics, 59(5), 1168–1169.
Knight, S. J., Flannery, A. V., Hirst, M. C., Campbell, L., Christodoulou, Z., Phelps, S. R., et al. (1993). Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell, 74(1), 127–134.
Knight, S., Ritchie, R., Chakrabarti, L., Cross, G., Taylor, G., Mueller, R., et al. (1996). A study of FRAXE in mentally retarded individuals referred for fragile X syndrome (FRAXA) testing in the United Kingdom. American Journal of Human Genetics, 58, 906–913.
Knight, S., Voelckel, M., Hirst, M., Flannery, A., Moncla, A., & Davies, K. (1994). Triplet repeat expansion at the FRAXE locus and X-linked mild mental handicap. Journal of Human Genetics, 55, 81–86.
Lord, C., Risi, S., Lambrecht, L., Cook, E., Leventhal, B., Dilavore, P., et al. (1989). Autism diagnostic observation schedule: A standardized observation of communicative and social behaviour. Journal of Autism and Developmental Disorders, 19, 185–212.
Lord, C., Rutter, M., & Le Couter, A. (1994). Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24, 659–685.
Melko, M., & Bardoni, B. (2010). The role of G-quadruplex in RNA metabolism: involvement of FMRP and FMR2P. Biochimie, 92(8), 919–926.
Melko, M., Douguet, D., Bensaid, M., Zongaro, S., Verheggen, C., Gecz, J., et al. (2011). Functional characterization of the AFF (AF4/FMR2) family of RNA-binding proteins: insights into the molecular pathology of FRAXE intellectual disability. Human Molecular Genetics, 20(10), 1873–1885.
Milà, M., Sànchez, A., Badenas, C., Brun, C., Jiménez, D., Villa, M. P., et al. (1997). Screening for FMR1 and FMR2 mutations in 222 individuals from Spanish special schools: identification of a case of FRAXE-associated mental retardation. Human Genetics, 100(5–6), 503–507.
Miller, W. L., Skinner, J. A., Foss, G. S., & Davies, K. E. (2000). Localization of the fragile X mental retardation 2 (FMR2) protein in mammalian brain. European Journal of Neuroscience, 12(1), 381–384.
Murray, A., Youings, S., Dennis, N., Latsky, L., Linehan, P., McKechnie, N., et al. (1996). Population screening at the FRAXA and FRAXE loci: Molecular analyses of boys with learning difficulties and their mothers. Human Molecular Genetics, 5(6), 727–735.
Nigro, C., Faravelli, F., Cavani, S., Perroni, L., Novello, P., Vitali, M., et al. (2000). FRAXE mutation in a mentally retarded subject and in his phenotypically normal twin brother. European Journal of Human Genetics, 8, 157–162.
Russo, S., Selicorni, A., Bedeshi, M. F., Natacci, F., Viziello, P., Fortuna, R., et al. (1998). Molecular characterization of FRAXE-positive subjects with mental impairment in two unrelated Italian families. American Journal of Medical Genetics, 75(3), 304–308.
Schopler, E., Reichler, R. J., Devellis, R. F., & Daly, K. (1980). Toward objective classification of childhood autism: Childhood Autism Rating Scale. Journal of Autism and Developmental Disorders, 10, 91–103.
Stettner, G. M., Shoukier, M., Hoger, C., Brockmann, K., & Auber, B. (2011). Familial intellectual disability and autistic behavior caused by a small FMR2 gene deletion. American Journal of Medical Genetics Part A, 155A(8), 2003–2007.
Sutherland, G. R., & Baker, E. (1992). Characterization of a new rare fragile site easily confused with the fragile X. Human Molecular Genetics, 1(2), 111–113.
Sutherland, G. R., & Baker, E. (2000). The clinical significance of fragile sites on human chromosomes. Clinical Genetics, 58(3), 157–161.
Wang, Q., Gu, Y., Ferguson, J., Chen, Q., Boatwright, Q., Gardiner, J., et al. (2003). Cytogenetic analysis of obsessive-compulsive disorder (OCD): Identification of a FRAXE fragile site. American Journal of Medical Genetics Part A, 118(1), 25–28.
Wechsler, D. (2003). Escala de Inteligência de Wechsler para Crianças—terceira edição (WISC-III). Adaptação portuguesa: Simões MR, Rocha A e Ferreira C. Cegoc Lisboa.
World Health Organization. (1992). ICD-10 classifications of mental and behavioural disorder: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.
Youings, S., Murray, A., Dennis, N., Ennis, S., Lewis, C., McKechnie, N., et al. (2000). FRAXA and FRAXE: The results of a five year survey. Journal of Medical Genetics, 37, 415–421.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Correia, F., Café, C., Almeida, J. et al. Autism Spectrum Disorder: FRAXE Mutation, a Rare Etiology. J Autism Dev Disord 45, 888–892 (2015). https://doi.org/10.1007/s10803-014-2185-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-014-2185-8